Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome
Cochrane database of systematic reviews, December 2014
Francesca Nava, Francesca Ghilotti, Lorenzo Maggi, Gulen Hatemi, Alessandra Del Bianco, Chiara Merlo, Graziella Filippini, Irene Tramacere
Neuro-Behçet Syndrome (NBS) is a severe chronic inflammatory vascular disease involving the Central Nervous System (CNS), and it is an invalidating condition with disability and a huge impact on quality of life. Recommendations on treatments for NBS include the use of disease-modifying therapies in general, although they are not supported by a systematic review of the evidence.
|Readers by professional status||Count||As %|
|Readers by discipline||Count||As %|